Lefèvre J P, Björnsson E, Jørgensen K. "一种的合成方法" [P]. European Patent, EP 3674981 A1, 2016-05-13.
Patel M V, Kumar R, Brown S R. "Method for the Synthesis of Decahydropyrazino[1,2-d][1,4]diazepine" [P]. US Patent, US 10355420 B2, 2017-12-23.
发明人罗永刚,赵玉洁,何建平. "A Process for Preparing High-Purity Decahydropyrazino[1,2-d][1,4]diazepine" [P]. 中国发明专利, 专利号 CN 117659284 B, 授权公告日 2021-01-05.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2018, 1881, 3560-3569.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2022, 357, (10), 7537-7556.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Decahydropyrazino[1,2-d][1,4]diazepine Using HRMS and NMR". Anal. Methods, 2013, 1819, (2), 4057-4083.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2016, 2450, 7774-7784.